Paralytic Subileus as an Adverse Effect of Amino Acid–Based Nephroprotection in a Patient Undergoing Peptide Receptor Radionuclide Therapy. (March 2015)

• Record Type: Journal Article
• Authors: Werner, Rudolf A.; Brumberg, Joachim; Dierks, Alexander; Herrmann, Ken; Biko, Johannes; Buck, Andreas K.; Lapa, Constantin
• Is Part Of: Clinical nuclear medicine. Volume 40:Number 3(2015)
• Publication Date: 2015-03
• Subjects: Nuclear medicine -- Periodicals; Radioisotope scanning -- Periodicals; Nuclear Medicine -- Periodicals; 616.07575
• DOI: 10.1097/RLU.0000000000000624
• Languages: English
• ISSNs: 0363-9762

Abstract

<abstract> <title> <x xml:space="preserve">Abstract</x> </title> <sec> <title>Abstract</title> <p>Peptide receptor radionuclide therapy is routinely used for neuroendocrine tumors. To prevent radiopeptide retention at the proximal tubule of the kidney, positively charged amino are coinfused. However, hyperkalemia (&gt;5.0 mmol/L) in more than three fourth of patients has been reported. In our case, the patient experienced acute hyperkalemia with blood values greater than 7.0 mmol/L with gastroparesis and subileus.</p> </sec> </abstract>